Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

Sector

Healthcare Facilities & Services

More about the company

Market Cap	47.46M 55.41M 44.41M 40.65M 76.29M 5.3B 77.3M 525M 205M 2.66B 208M 204M 8.81B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	47.59M 55.55M 44.52M 40.76M 76.49M 5.32B 77.5M 526M 205M 2.67B 209M 204M 8.83B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

08-11	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
04-01	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI

07-15	Klea : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	PU
07-15	Klea Holding : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	AT
06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT

08-17	Klea : Déclaration des transactions sur actions propres
08-17	Klea Holding : Déclaration des transactions sur actions propres
07-27	Klea Holding : Déclaration des transactions sur actions propres
07-20	Klea Holding : Déclaration des transactions sur actions propres
07-15	Klea Holding vise une amélioration de sa rentabilité au second semestre

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

VISIOMED Stock Deutsche Boerse AG

Stocks

Healthcare Facilities & Services

Valuation: VISIOMED

Latest news : VISIOMED

Analysts' recommendations: VISIOMED

Press Releases: VISIOMED

News in other languages: VISIOMED

Managers and Directors: VISIOMED

Other Healthcare Facilities & Services

Financials

Company Profile

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VISIOMED	-.--%	-.--%	-	-	55.43M
CVS HEALTH CORPORATION	-0.67%	-2.07%	+31.35%	+39.23%	120B
HCA HEALTHCARE, INC.	+5.64%	+4.24%	+4.63%	+59.53%	87.96B
QUEST DIAGNOSTICS INCORPORATED	+1.28%	+3.54%	+32.53%	+83.06%	26.63B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.25%	+4.12%	-3.88%	-9.17%	22.17B
TENET HEALTHCARE CORPORATION	+3.00%	+5.14%	+54.32%	+297.24%	21.95B
REDE D'OR SÃO LUIZ S.A.	+1.48%	+1.75%	-8.03%	+14.24%	14.2B
FRESENIUS MEDICAL CARE AG	-1.83%	-2.07%	-7.32%	-9.94%	12.66B
DAVITA INC.	-0.81%	-2.99%	+26.49%	+71.15%	11.18B
PT SEJAHTERARAYA ANUGRAHJAYA TBK	-1.74%	+8.46%	+127.42%	+2,036.36%	9.88B
Average	+0.76%	-0.56%	+28.61%	+286.86%	36.27B
Weighted average by Cap.	+1.53%	-0.64%	+22.93%	+120.90%

	2024	2025
Net sales	17.26M 20.15M 16.15M 14.78M 27.74M 1.93B 28.11M 191M 74.41M 968M 75.66M 74.01M 3.2B	22.17M 25.88M 20.74M 18.99M 35.63M 2.48B 36.1M 245M 95.56M 1.24B 97.16M 95.05M 4.11B
Net income	1.4M 1.64M 1.31M 1.2M 2.26M 157M 2.29M 15.53M 6.06M 78.83M 6.16M 6.02M 261M	2.28M 2.66M 2.13M 1.95M 3.67M 255M 3.71M 25.22M 9.83M 128M 10M 9.78M 423M
Net Debt	2.58M 3.01M 2.41M 2.21M 4.14M 288M 4.19M 28.47M 11.1M 144M 11.29M 11.04M 478M	125K 146K 117K 107K 201K 13.96M 204K 1.38M 539K 7.01M 548K 536K 23.2M